Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Inhibitor-resistant TEM beta-lactamases: revision of the TEM-41 sequence.

Labia R, Chaibi EB, Sirot D, Chanal-Claris C, Stapleton P, Shannon K, French G.

Antimicrob Agents Chemother. 1998 Oct;42(10):2771. No abstract available.

2.

Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Sirot D, Labia R, Pouedras P, Chanal-Claris C, Cerceau C, Sirot J.

Antimicrob Agents Chemother. 1998 Sep;42(9):2184-7.

3.

Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis.

Bret L, Chanal-Claris C, Sirot D, Chaibi EB, Labia R, Sirot J.

Antimicrob Agents Chemother. 1998 May;42(5):1110-4.

4.

Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244.

Bret L, Chaibi EB, Chanal-Claris C, Sirot D, Labia R, Sirot J.

Antimicrob Agents Chemother. 1997 Nov;41(11):2547-9.

5.

A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.

Sirot D, Recule C, Chaibi EB, Bret L, Croize J, Chanal-Claris C, Labia R, Sirot J.

Antimicrob Agents Chemother. 1997 Jun;41(6):1322-5.

6.

Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.

Chanal-Claris C, Sirot D, Bret L, Chatron P, Labia R, Sirot J.

Antimicrob Agents Chemother. 1997 Mar;41(3):715-6.

Supplemental Content

Loading ...
Support Center